Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FW4LB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,024
Award facts
- Contract value 100% obligated
- $16,024.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $16,024.40 delivery order to Amerisourcebergen Drug Corp on February 13, 2026, for Dupixent 300 mg/2 ml syringes.
Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of February 17, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FW4LB?
SPE2DR26FW4LB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 13, 2026.
How much is contract SPE2DR26FW4LB worth?
The government has obligated $16,024 on SPE2DR26FW4LB.
Is contract SPE2DR26FW4LB an order under another contract?
Yes. SPE2DR26FW4LB is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW4LB competed?
The extent of competition for SPE2DR26FW4LB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award